WallStreetZenWallStreetZen

NASDAQ: PLSE
Pulse Biosciences Inc Stock

$15.96-0.46 (-2.8%)
Updated Jul 19, 2024
PLSE Price
$15.96
Fair Value Price
$0.73
Market Cap
$881.40M
52 Week Low
$3.78
52 Week High
$20.44
P/E
-19.7x
P/B
24.29x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$42.55M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.36
Operating Cash Flow
-$36M
Beta
1.16
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PLSE Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PLSE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PLSE ($15.96) is overvalued by 2,076.79% relative to our estimate of its Fair Value price of $0.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PLSE ($15.96) is not significantly undervalued (2,076.79%) relative to our estimate of its Fair Value price of $0.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PLSE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PLSE due diligence checks available for Premium users.

Be the first to know about important PLSE news, forecast changes, insider trades & much more!

PLSE News

Valuation

PLSE fair value

Fair Value of PLSE stock based on Discounted Cash Flow (DCF)
Price
$15.96
Fair Value
$0.73
Overvalued by
2,076.79%
PLSE ($15.96) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PLSE ($15.96) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PLSE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PLSE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-19.7x
Industry
55.7x
Market
29.62x

PLSE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
24.29x
Industry
3.71x
PLSE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PLSE's financial health

Profit margin

Revenue
$0.0
Net Income
-$10.1M
Profit Margin
0%
PLSE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$49.2M
Liabilities
$12.9M
Debt to equity
0.36
PLSE's short-term assets ($35.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PLSE's short-term assets ($35.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PLSE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PLSE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.8M
Investing
-$5.0k
Financing
$305.0k
PLSE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PLSE vs Medical Stocks

TickerMarket Cap1d %P/EP/B
PLSE$881.40M-2.80%-19.70x24.29x
ATRI$804.30M+0.09%42.99x3.32x
BLFS$967.57M-2.00%-14.80x2.90x
EMBC$759.52M-1.35%10.80x-0.99x
ATRC$1.17B-2.03%-30.21x2.56x

Pulse Biosciences Stock FAQ

What is Pulse Biosciences's quote symbol?

(NASDAQ: PLSE) Pulse Biosciences trades on the NASDAQ under the ticker symbol PLSE. Pulse Biosciences stock quotes can also be displayed as NASDAQ: PLSE.

If you're new to stock investing, here's how to buy Pulse Biosciences stock.

What is the 52 week high and low for Pulse Biosciences (NASDAQ: PLSE)?

(NASDAQ: PLSE) Pulse Biosciences's 52-week high was $20.44, and its 52-week low was $3.78. It is currently -21.91% from its 52-week high and 322.22% from its 52-week low.

How much is Pulse Biosciences stock worth today?

(NASDAQ: PLSE) Pulse Biosciences currently has 55,225,333 outstanding shares. With Pulse Biosciences stock trading at $15.96 per share, the total value of Pulse Biosciences stock (market capitalization) is $881.40M.

Pulse Biosciences stock was originally listed at a price of $4.17 in May 18, 2016. If you had invested in Pulse Biosciences stock at $4.17, your return over the last 8 years would have been 282.73%, for an annualized return of 18.27% (not including any dividends or dividend reinvestments).

How much is Pulse Biosciences's stock price per share?

(NASDAQ: PLSE) Pulse Biosciences stock price per share is $15.96 today (as of Jul 19, 2024).

What is Pulse Biosciences's Market Cap?

(NASDAQ: PLSE) Pulse Biosciences's market cap is $881.40M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pulse Biosciences's market cap is calculated by multiplying PLSE's current stock price of $15.96 by PLSE's total outstanding shares of 55,225,333.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.